← Back to directory
Nadia Harbeck
Researcher Next ID · RN-001915
Researcher · Biochemistry, Genetics and Molecular Biology
Munich, Germany
Not currently recruitingFunding unknown
- Works count
- 2,060
- Citation count
- 87,947
- H-index
- 134
- i10-index
- 626
Research interests
Biochemistry, Genetics and Molecular Biology
Medicine
Breast Cancer Treatment Studies
Advanced Breast Cancer Therapies
HER2/EGFR in Cancer Research
Cancer Treatment and Pharmacology
Estrogen and related hormone effects
Publications
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
New England Journal of Medicine · 2022 · https://doi.org/10.1056/nejmoa2203690
Pembrolizumab for Early Triple-Negative Breast Cancer
New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa1910549
Breast cancer
Nature Reviews Disease Primers · 2019 · https://doi.org/10.1038/s41572-019-0111-2
Palbociclib and Letrozole in Advanced Breast Cancer
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1607303
Breast cancer
The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)31891-8
Current projects
No projects listed.